Sample size of 360 children with typhoid fever were enrolled and randomly divided in two groups. All the children were enrolled in the trial from Pediatrics emergency. Informed consent was obtained from parents. Demographics (name, age of child, sex of the child, duration of fever, weight, season, socioeconomic status and residence) were noted. Then children were admitted and randomly divided in two groups by using lottery method. In group A, children were given oral 200 mg levofloxacin tablet. In group B, children were given oral 900-1,000 mg ciprofloxacin tablet. All children were followed-up pediatric wards for 7 days. If fever was resolved within 5 days (body temperature falls <99oF and remain stable for at least 5 days), then efficacy was labeled. Total time required to resolve fever i.e. body temperature <99oF in all children was also noted. All this information was recorded

Inclusion Criteria:

• Children of age 1-12 years
• Typhoid fever
• Confirmed on blood culture

Exclusion Criteria:

• Recurrent typhoid within 3 months
• Intestinal perforation
• Evidence of progressive or complicated disease
• Inability to swallow oral medication
• Hypersensitivity to trial drugs
• Already taken fluoroquinolone, third generation cephalosporin or macrolide in last week